Recent Company News

• 04:55 AM ET Jul 22, 2025
  

  Sino Biopharmaceutical completes first subject dosing for TQB6411 injection to treat tumors (HK$6.90, 0.00)

• 03:35 AM ET Jul 22, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (46 total)

• 11:16 AM ET Jul 21, 2025
  

  StreetAccount M&A Summary: Week of 14-Jul

• 03:48 AM ET Jul 18, 2025
  

  StreetAccount Summary: China Stocks reaching new 52-week highs/lows (28 total)

• 11:53 PM ET Jul 16, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (83 total)

• 04:05 AM ET Jul 16, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (23 total)

• 11:48 PM ET Jul 15, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (102 total)

• 06:41 AM ET Jul 15, 2025
  

  Sino Biopharmaceutical to acquire LaNova Medicines for $950.9M (HK$7.46B) (HK$6.37, 0.00)

• 03:51 AM ET Jul 15, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (29 total)

• 11:49 PM ET Jul 14, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (95 total)